Pharmacokinetic, Safety, Tolerability, and Immunogenicity Study of SB8 in Healthy Male Subjects
Clinical trial NCT02453672 · COMPLETED
Trial details
- NCT number
- NCT02453672
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-09-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.